Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Prostate Cancer, CTC”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableWithdrawnNCT02742259
What this trial is testing

Validation of the Prostate Cancer Assay - Beta+Pivotal

Who this might be right for
Metastatic Prostate Cancer, CTC
Celsee Diagnostics
Testing effectiveness (Phase 2)Ended earlyNCT00887640
What this trial is testing

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 11
Testing effectiveness (Phase 2)UnknownNCT03050866
What this trial is testing

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)

Who this might be right for
Circulating Tumor CellMetastatic Prostate Cancer
Erasmus Medical Center 140
Testing effectiveness (Phase 2)Study completedNCT03101046
What this trial is testing

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

Who this might be right for
Prostate CarcinomaCastration-resistant Prostate CancerCirculating Tumor Cells+1 more
UNICANCER 40
Not applicableEnded earlyNCT05437679
What this trial is testing

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

Who this might be right for
High Risk Prostate CarcinomaBiochemically Recurrent Prostate CarcinomaCastration-resistant Prostate Cancer+1 more
Angle plc 9
Not applicableUnknownNCT05947188
What this trial is testing

Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC)

Who this might be right for
Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University 808
Not applicableUnknownNCT04628806
What this trial is testing

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells

Who this might be right for
Melanoma Stage IVSarcomaSquamous Cell Carcinoma+3 more
Charite University, Berlin, Germany 120
Not applicableStudy completedNCT04021394
What this trial is testing

Influence of EMT on CTCs and Disease Progression in Prostate Cancer

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 31
Not applicableEnded earlyNCT04581109
What this trial is testing

Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)

Who this might be right for
Prostate Cancer
University Hospital, Montpellier 100
Large-scale testing (Phase 3)Ended earlyNCT03327662
What this trial is testing

Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 12
Not applicableLooking for participantsNCT06904625
What this trial is testing

Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Prostate Cancer
Institut Claudius Regaud 54
Not applicableLooking for participantsNCT01961713
What this trial is testing

Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 200
Not applicableLooking for participantsNCT06469710
What this trial is testing

A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients

Who this might be right for
Prostate CancerCirculating Tumor CellLeukapheresis
RenJi Hospital 50
Not applicableStudy completedNCT02456571
What this trial is testing

CTC Immune Checkpoint

Who this might be right for
Prostate Cancer
Duke University 38
Not applicableWithdrawnNCT05245435
What this trial is testing

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna
Not applicableLooking for participantsNCT02997709
What this trial is testing

Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients

Who this might be right for
Prostate Cancer
University of Miami 144
Testing effectiveness (Phase 2)WithdrawnNCT02065323
What this trial is testing

Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

Who this might be right for
Prostate Cancer
Oscar Goodman, Jr.
Testing effectiveness (Phase 2)Ended earlyNCT01499043
What this trial is testing

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Daiichi Sankyo 6
Not applicableUnknownNCT03979339
What this trial is testing

Feasibility of a New Technology for Isolating Circulating Tumour Cells

Who this might be right for
HER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more
Centre Oscar Lambret 76
Not applicableUnknownNCT03089099
What this trial is testing

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Fudan University 100
Next Page